BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Hedge Fund Takes Another Shot at Biotech, This Time at Prothena

  Kerrisdale believes that Prothena’s lead drug NEOD001 will fail in its current Phase 2b and Phase 3 trials.

  November 8, 2017

   · 

  1 min read
• Policy

  Virtual Imaging, a Canon Company, Receives ISO 13485:2003 Certification

  Bolstering its healthcare credentials, Canon U.S.A. has been registered by Intertek Testing Services NA as conforming to the requirements of ISO 13485:2003 for the design, manufacture, installation and service of digital radiographic x-ray systems.

  November 8, 2017

   · 

  4 min read
• Business

  Zealand Pharma: Interim Report for the First Nine Months of 2017

  Financial guidance for 2017 has been revised with 4-6% lower operating expenses.

  November 8, 2017

   · 

  4 min read
• Guangzhou’s AnchorDx Raises $28M for Precision Oncology Offerings

  The round was led by 6 Dimensions Capital, the company formed earlier this year by the merger of WuXi Healthcare Ventures and Frontline BioVentures, along with Sijia Jianxin Fund.

  November 8, 2017

   · 

  1 min read
• Business

  Immuron’s Travelan Experiences Strong Q1 FY2018 Sales Growth

  Travelan U.S. experienced a 197% increase in sales compared to Q1 2017.

  November 8, 2017

   · 

  4 min read
• Drug Development

  Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Clinical Trial of RX-3117 in Combination with Abraxane in Patients Newly Diagnosed With Metastatic Pancreatic Cancer

  Abraxane (albumin-bound paclitaxel) is commonly used in the treatment of pancreatic cancer in combination with other chemotherapies.

  November 8, 2017

   · 

  8 min read
• 

  Business

  MEDITE Cancer Diagnostics Names a New CEO

  On November 5, 2017, David Patterson, the previous CEO and Chairman notified the Board that he is retiring.

  November 8, 2017

   · 

  4 min read
• Drug Development

  Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine

  M207-ADAM is an open label study evaluating the safety of the 3.8mg dose of zolmitriptan in migraine patients who have historically experienced at least 2 migraines per month.

  November 8, 2017

   · 

  5 min read
• Business

  Jounce Therapeutics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 13, 2017

  Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 8:00 a.m. ET.

  November 8, 2017

   · 

  1 min read
• Deals

  Mesa Labs Acquires Sterilization and Disinfection Process Control Business

  Mesa purchased only the Hygiene Monitoring business from BAG and as a result, the sale and service of their other business divisions will continue as normal and are not affected in any way by the acquisition of the Hygiene Monitoring business.

  November 8, 2017

   · 

  4 min read